Lupin Q2 Results: Net profit soars 74% YoY to Rs 853 crore on strong demand for generic drugs

November 7, 2024

Lupin exceeded profit expectations in the second quarter, reporting a 74% surge in profits, reaching ₹8.53 billion. This growth was fueled by robust demand for their respiratory and diabetes medications. Overall revenue also saw an 11.3% increase, reaching ₹54.97 billion.

More To Explore

Tata Sons Chairman N Chandrasekaran’s salary package jumps 15% to Rs 156 crore

N Chandrasekaran earned ₹155.81 crore in FY25, up 15% YoY, cementing his spot as India’s highest-paid executive. Despite a 24.3% profit drop at Tata Sons,

July 24, 2025

Top 5 states contribute over 65% to total mutual fund industry AAUM in June 2025: ICRA Analytics

Maharashtra led mutual fund AAUM contributions with 40.61%, as five states together accounted for over 65% of the total. Nagaland saw the highest yearly AAUM

July 24, 2025

Advertiser Disclosure

Great-investor.com helps users across the globe to find out The latest news, Guides, and Info about finance and investments. Furthermore, our content and research teams do not participate in any advertising planning nor are they permitted access to advertising campaign data.

Disclaimer

It is our organization’s primary mission to provide reviews, commentary, and analysis that are unbiased and objective. While great-investor.com has some data verified by industry participants, it can vary from time to time. Operating as an online business, this site may be compensated through third party advertisers. Our receipt of such compensation shall not be construed as an endorsement or recommendation by great-investor.com, nor shall it bias our reviews, analysis, and opinions. Please see our General Disclaimers for more information

Top10 International FZ LLE | 17th Floor, Creative Tower | 4422 | Fujairah | TRN: 100608946800003